ReviewCancer Biomark2022
Applications of artificial intelligence (AI) in ovarian cancer, pancreatic cancer, and image biomarker discovery.
- Journal
- Cancer Biomark
- Published
- 1 January 2022
- Citations
- 36
- Type
- Review
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Background Artificial intelligence (AI), including machine learning (ML) and deep learning, has the potential to revolutionize biomedical research. Defined as the ability to "mimic" human intelligence by machines executing trained algorithms, AI methods are deployed for biomarker discovery. … Excerpt only: this text is the publisher’s. Read it in full at the source.